Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiachang Gong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Organic Letters|April 23, 2004
Remote substituents influence both the thermodynamics and kinetics of zinc binding to tris-pyridyl methanol derivativesJiachang Gong, Bruce C Gibb
Journal of the American Chemical Society|April 4, 2007
A synthetic nucleoside probe that discerns a DNA adduct from unmodified DNAJiachang Gong, Shana J Sturla
Chemical Communications (Cambridge, England)|March 10, 2005
A new macrocycle demonstrates ditopic recognition propertiesJiachang Gong, Bruce C Gibb
Chemical Communications (Cambridge, England)|June 29, 2005
Polyfunctionalized macrocycles demonstrate enantioselective and ditopic binding propertiesJiachang Gong, Bruce C Gibb
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy SubjectsJiachang Gong, Lars Hansen, Lisa Iacono
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 13, 2011
Identification of the oxidative and conjugative enzymes involved in the biotransformation of brivanibJiachang Gong, Jinping Gan, Ramaswamy A Iyer
Chemical Research in Toxicology|September 29, 2007
Quantitative correlation of drug bioactivation and deoxyadenosine alkylation by acylfulveneJames F Neels, Jiachang Gong, Xiang Yu, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic dataJiachang Gong, Lisa Iacono, Ramaswamy A Iyer, et al.
Chemical Research in Toxicology|September 24, 2011
Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediatesKathryn E Pietsch, James F Neels, Xiang Yu, et al.
Journal of Medicinal Chemistry|April 14, 2006
Investigating the role of stereochemistry in the activity of anticancer acylfulvenes: synthesis, reductase-mediated bioactivation, and cellular toxicityJiachang Gong, James F Neels, Xiang Yu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Organic Letters|April 23, 2004
Remote substituents influence both the thermodynamics and kinetics of zinc binding to tris-pyridyl methanol derivativesJiachang Gong, Bruce C Gibb
Journal of the American Chemical Society|April 4, 2007
A synthetic nucleoside probe that discerns a DNA adduct from unmodified DNAJiachang Gong, Shana J Sturla
Chemical Communications (Cambridge, England)|March 10, 2005
A new macrocycle demonstrates ditopic recognition propertiesJiachang Gong, Bruce C Gibb
Chemical Communications (Cambridge, England)|June 29, 2005
Polyfunctionalized macrocycles demonstrate enantioselective and ditopic binding propertiesJiachang Gong, Bruce C Gibb
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy SubjectsJiachang Gong, Lars Hansen, Lisa Iacono
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 13, 2011
Identification of the oxidative and conjugative enzymes involved in the biotransformation of brivanibJiachang Gong, Jinping Gan, Ramaswamy A Iyer
Chemical Research in Toxicology|September 29, 2007
Quantitative correlation of drug bioactivation and deoxyadenosine alkylation by acylfulveneJames F Neels, Jiachang Gong, Xiang Yu, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic dataJiachang Gong, Lisa Iacono, Ramaswamy A Iyer, et al.
Chemical Research in Toxicology|September 24, 2011
Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediatesKathryn E Pietsch, James F Neels, Xiang Yu, et al.
Journal of Medicinal Chemistry|April 14, 2006
Investigating the role of stereochemistry in the activity of anticancer acylfulvenes: synthesis, reductase-mediated bioactivation, and cellular toxicityJiachang Gong, James F Neels, Xiang Yu, et al.
Pageof 2